Dear Contractor |
Please see attached correspondence from the Department of Health. |
SUMMARY
- A number of individuals remain eligible for LFD tests and should be able to access these freely without the need to purchase privately. This is particularly important for those in advance of inpatient admission or treatment.
- Pharmacies may experience an increase in demand due to the recommencement of the PANORAMIC antiviral study. Recruitment for the study closed on 27 April 2022.
- From 23 November 2022, eligible members of the public in Northern Ireland can register for the study. More information on the study, including study eligibility and how people can sign up, is available at the PANORAMIC trial website.
- PANORAMIC is open to anyone that meets the following criteria:
- You are currently experiencing COVID-19 symptoms, beginning in the last 5
days; - AND You have had a positive PCR or Lateral Flow test for COVID-19;
- AND You are aged 50 or over, or aged 18 or over with a LISTED pre-existing condition.
- You are currently experiencing COVID-19 symptoms, beginning in the last 5
- Further information for the public is also available on NI Direct Treatments for coronavirus (COVID-19) webpage which details the above eligibility information and states if a person is in an eligible group. If they wish to take part in the study they can collect lateral flow tests from participating pharmacies.
- People are advised they should not collect tests from a pharmacy if they have symptoms but should ask someone who does not have symptoms to collect the lateral flow tests on their behalf.
ACTION
- Contractors are asked to review the attached correspondence and ensure pharmacy teams are aware of the communication.
- Please ensure you retain sufficient stock to meet any increases in demand.
- If you have any further queries, please contact the CPNI office.
Kind regards

GERARD GREENE
Chief Executive